Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paolo G Gobbi

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
Critical Reviews in Oncology/Hematology|December 3, 2013
Tumor burden in Hodgkin's lymphoma: much more than the best prognostic factorPaolo G Gobbi
Critical Reviews in Oncology/Hematology|May 20, 2011
What has happened to VBM (vinblastine, bleomycin, and methotrexate) chemotherapy for early-stage Hodgkin lymphoma?Paolo G Gobbi, Massimo Federico
Oncology Letters|August 7, 2012
Prolonged survival in advanced thymoma: Effectiveness of sequential multiple lines of chemotherapy in an inoperable caseManuela Bergonzi, Giulio Orlandoni, Franco Corbella, et al.
Oncology Letters|September 12, 2012
Role of conventional salvage multiple-drug chemotherapy in relapsed and refractory aggressive non-Hodgkin lymphomasPaolo G Gobbi, Lara Villano, Donatella Pozzoli, et al.
Blood|January 25, 2012
How I treat enteropathy-associated T-cell lymphomaAntonio Di Sabatino, Federico Biagi, Paolo G Gobbi, et al.
Critical Reviews in Oncology/Hematology|August 8, 2012
Hodgkin lymphomaPaolo G Gobbi, Andrés J M Ferreri, Maurilio Ponzoni, et al.
Hematological Oncology|October 31, 2012
Tumour burden at diagnosis as the main clinical predictor of cell resistance in patients with early stage, favourable Hodgkin lymphoma treated with VBM chemotherapy plus radiotherapyPaolo G Gobbi, Manuela Bergonzi, Emilio Bassi, et al.
Haematologica|November 5, 2002
Lymphomatous superficial lymph nodes: limitations of physical examination for accurate staging and response assessmentPaolo G Gobbi, Chiara Broglia, Gabriella Carnevale Maffè, et al.
Mayo Clinic Proceedings|June 6, 2015
Long-Term Follow-Up of Crohn Disease Fistulas After Local Injections of Bone Marrow-Derived Mesenchymal Stem CellsRachele Ciccocioppo, Alessandra Gallia, Adele Sgarella, et al.
British Journal of Haematology|July 9, 2002
Clinical and biological effects of treatment with amifostine in myelodysplastic syndromesRosangela Invernizzi, Alessandro Pecci, Erica Travaglino, et al.
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Critical Reviews in Oncology/Hematology|December 3, 2013
Tumor burden in Hodgkin's lymphoma: much more than the best prognostic factorPaolo G Gobbi
Critical Reviews in Oncology/Hematology|May 20, 2011
What has happened to VBM (vinblastine, bleomycin, and methotrexate) chemotherapy for early-stage Hodgkin lymphoma?Paolo G Gobbi, Massimo Federico
Oncology Letters|August 7, 2012
Prolonged survival in advanced thymoma: Effectiveness of sequential multiple lines of chemotherapy in an inoperable caseManuela Bergonzi, Giulio Orlandoni, Franco Corbella, et al.
Oncology Letters|September 12, 2012
Role of conventional salvage multiple-drug chemotherapy in relapsed and refractory aggressive non-Hodgkin lymphomasPaolo G Gobbi, Lara Villano, Donatella Pozzoli, et al.
Blood|January 25, 2012
How I treat enteropathy-associated T-cell lymphomaAntonio Di Sabatino, Federico Biagi, Paolo G Gobbi, et al.
Critical Reviews in Oncology/Hematology|August 8, 2012
Hodgkin lymphomaPaolo G Gobbi, Andrés J M Ferreri, Maurilio Ponzoni, et al.
Hematological Oncology|October 31, 2012
Tumour burden at diagnosis as the main clinical predictor of cell resistance in patients with early stage, favourable Hodgkin lymphoma treated with VBM chemotherapy plus radiotherapyPaolo G Gobbi, Manuela Bergonzi, Emilio Bassi, et al.
Haematologica|November 5, 2002
Lymphomatous superficial lymph nodes: limitations of physical examination for accurate staging and response assessmentPaolo G Gobbi, Chiara Broglia, Gabriella Carnevale Maffè, et al.
Mayo Clinic Proceedings|June 6, 2015
Long-Term Follow-Up of Crohn Disease Fistulas After Local Injections of Bone Marrow-Derived Mesenchymal Stem CellsRachele Ciccocioppo, Alessandra Gallia, Adele Sgarella, et al.
British Journal of Haematology|July 9, 2002
Clinical and biological effects of treatment with amifostine in myelodysplastic syndromesRosangela Invernizzi, Alessandro Pecci, Erica Travaglino, et al.
Pageof 5